Management of triple-negative invasive ductal cell carcinoma

We reported a case of triple-negative breast cancer who presented to our medical center with a mass in the upper outer quadrant of the left breast. The age of the patient at the time of presentation was 74 years and 8 months. Breast ultrasound revealed a 3.3 cm × 2.7 cm lobulated hypoechoic fibroglandular mass in the upper outer quadrant of the left breast. Core biopsy showed triple-negative (estrogen receptor/progesterone receptor/human epidermal growth factor receptor 2/neu negative) invasive ductal cell cancer of the left breast infiltrating into the skin but no fixation to the chest wall. Neoadjuvant chemotherapy reduced the size of the mass to 2.1 cm × 1.2 cm. Partial mastectomy was then performed along with partial axillary dissection and adjuvant radiotherapy. No recurrence of tumor or any recent breast mass was noted at 1-year follow-up on both mammography and ultrasonography, indicating successful management of triple-negative breast tumor. We conclude that triple-negative breast tumors should be managed with neoadjuvant chemotherapy such as taxanes and cisplatins followed by adjuvant radiotherapy.